Login
Navigate Fool.com
Will ANTH beat
the market?
Community Rating: 3 Stars: Appealing

2.87 -0.01 (-0.35%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.90
Previous Close $2.88
Daily Range $2.85 - $2.91
52-Week Range $2.63 - $5.04
Market Cap $57.5M
P/E Ratio -1.70
Dividend (Yield) $0.00 (0.0%)
Volume 23,876
Average Daily Volume 138,884
Current FY EPS -$2.20

How do you think ANTH
will perform against the market?

Top ANTH Bull/Bear Pitches

 

AllStarPortfolio (< 20)
Submitted October 15, 2010

On September 13, 2010 at 1:05 PM, zzlangerhans (99.50) wrote: My next selection: Anthera Pharmaceuticals (ANTH). Please enter a limit pick of 3.4. Anthera is the Oliver Twist of baby biotech … More

1 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted October 25, 2011

Anthera is another volatility poster child. Within the last year or so up from 2.85 to 6.79, back down to 3.88, up to 8.5, down to 4.63, and now back up over 7. And all of that has occurred in the abs … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

A Potential 36-Bagger Biotech

Anthera starts its phase 3 program for blisibimod.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiducia

Insiders Buy Stocks in National Beverage, and Sell Costco

Plus, a purchase of Anthera Pharmaceuticals and a sale of NVR.

New Stock Coverage: Berry Plastics Looks Fantastic

Wall Street ratings agencies set the tone for today's stock market.

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — June 29, 2012: Stocks Soar on European Bailout News

Top Analyst Upgrades & Downgrades (ANTH, BBBY, BLK, BPL, CZR, CELG, EEP, FB, F, LNCR, NKE, ORCL, RIM

Top Analyst Upgrades & Downgrades (ANTH, BBBY, BLK, BPL, CZR, CELG, EEP, FB, F, LNCR, NKE, ORCL, RIMM, SKS, TTM, TIF, UNP, UHS, WETF, ZUMZ)

24/7 Wall St. Closing Bell — June 28, 2012: Obamacare Ruling Big News, But Hard to Figure Impact Thi

24/7 Wall St. Closing Bell — June 28, 2012: Obamacare Ruling Big News, But Hard to Figure Impact This Quickly

See More ANTH News...

Sector

Healthcare

Industry

Drugs

Anthera Pharmaceuticals, Inc. (ANTH) Description

Anthera Pharmaceuticals Inc. is a Biopharmaceutical Company focusing on developing and commercializing products to treat serious diseases associated with inflammation including cardiovascular and autoimmune diseases. Website: http://www.anthera.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks